Chief Scientific Officer- Drug Development

Dr. Ankit Borisa

9 Years Of Experience in pharmaceutical industry

With 10 years of cross-functional experience in Pharmaceutical R&D, Project Management, Portfolio Strategy, and Regulatory Affairs, Dr. Ankit C. Borisa, Ph.D. is a Techno-Commercial Project Manager specializing in NDA, ANDA, and API development and serving as Technical Head at ACUNPHARM LIFESCIENCE LLP, he leads new product development, API sourcing, strategic alliances, and commercialization efforts. His expertise spans generic drug development, regulatory compliance across global markets (USA, Europe, Brazil, China, Japan), and business expansion strategies. With prior roles at Sun Pharma, Amneal Pharmaceuticals, and ICMR, he has owned skills in Drug Master File (DMF) reviews, supplier qualification, risk analysis, and regulatory strategy. A certified Project Manager (Princeton Academy) and expert in Scifinder, Reaxy, SAP, and regulatory databases, he is driven by scientific innovation, business strategy, and operational excellence. A Decent expertise with Hospital partnership with Doctors that benefits to Patient in healthcare system.

Strategic Alliance and Business Development, Scientific Development and Project Management. End to End Process optimization and monitoring for smooth flow of work in Pharmaceutical Dosage forms and APIs.

My background encompasses leadership success across multifunctional areas of expertise, including Strategic alliance & Sourcing, Project management of new products from R&D level toplant execution process, filing and successful launching of the product in various markets. Throughout my career of RnD scientist 3 yrs and Project Manager 6 yrs , I have earned a solid reputation for rapidly adapting to new methodology & technology during handling of projects from inception through implementation. My keen business insight will provide you an invaluable resource. Well worse with knowledge of Medicinal Chemistry, Research and Development experience of NCE development, NDA AND ANDA generic market trends, business forecasting, Regulations & patents, all are assets of my work.